Humeca
Humeca is a Dutch medical device manufacturer specializing in skin grafting instruments for burn surgery, including the proprietary MEEK micrografting technique, cordless dermatomes, and meshers, sold globally through direct sales and distribution partners in over 80 countries.
- Company typePrivate
- Founded1981
- HeadquartersBorne, Netherlands
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Humeca does
Humeca, headquartered in Borne, The Netherlands, is a privately held medical device company founded in 1981 that develops, manufactures, and distributes skin grafting instruments for burn surgery. Its portfolio centers on the MEEK micrografting system—a technique re-engineered by Humeca in 1993 in cooperation with surgeons at the Red Cross Hospital Beverwijk that cuts 42mm × 42mm skin grafts into 3mm × 3mm micrografts and applies them to wound beds using pre-folded gauzes at expansion ratios of 1:2, 1:3, 1:4, 1:6, and 1:9. Supporting products include the D80 and D42 cordless battery-operated dermatomes launched in 2002 (the D42 is purpose-built for the MEEK technique and pediatric surgery, with blade speeds exceeding 7,000 strokes per minute), meshers and disposable V-carriers introduced in 2007 featuring a proprietary spring mechanism that extends blade axle life, and a line of manual knives (Humby, Humby Long, Watson, Cobbett, Silver) for free-hand graft harvesting. All products are manufactured in The Netherlands under EN ISO 13485:2016 certification.
The company generates revenue primarily from capital equipment sales and recurring consumables (disposable blades, V-carriers, and pre-folded gauzes) through three channels: its Netherlands headquarters, its wholly-owned US subsidiary Humeca Inc. in North Miami Beach, Florida, and an exclusive distribution partner network covering more than 80 countries, including Intermed for Australia/New Zealand, Marsap for India, and Ridge Biomed for Malaysia. Customers include specialized burn centers, plastic and reconstructive surgeons, and humanitarian medical organizations operating in resource-limited settings (e.g., Stichting Interplast Holland in Uganda). Go-to-market combines direct field sales, distributor relationships, conference participation at major burn care events (ANZBA, EBA, APBC), and structured MEEK surgeon certification programs.
Humeca's competitive position is anchored on its exclusive ownership of the modernized MEEK technique, more than four decades of focused specialization in burn surgery instruments since pivoting from general mechanical engineering, and an established clinical relationship network led by the Burn Center Red Cross Hospital Beverwijk and Maasstad Hospital Rotterdam. The leadership team includes CEO Arnoud van Velzen, COO Arjan van de Wolfshaar, and CCO Luis Irarragorri. In 2025 the company actively expanded its geographic footprint with new exclusive distributor partnerships in Australia and New Zealand, its first Latin American distributor meeting in Lima, Peru, and its inaugural MEEK Certification program in Latin America conducted with CENQUER.
Humeca firmographics
Firmographics- Name
- Humeca
- Legal name
- Humeca BV
- Website
- https://humeca.com
- Company type
- Private
- Founded year
- 1981
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Humeca is a Dutch medical device manufacturer specializing in skin grafting instruments for burn surgery, including the proprietary MEEK micrografting technique, cordless dermatomes, and meshers, sold globally through direct sales and distribution partners in over 80 countries.
- Ownership category
- akta.pro rank
Humeca industry classification
Industry- Product category
- Medical Devices for Burn Surgery / Skin Grafting Equipment
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE)
- akta.pro secondary industries
- Wound Healing & Skin Regeneration (advanced dressings, skin substitutes) (HLAAAGAG), Wound Care & Ulcer Management (HLAKACAN)
Keywords
Where Humeca is headquartered
LocationHeadquarters
- HQ city
- Borne
- HQ country
- Netherlands
- HQ region
- Europe
Offices2 records
Markets served
Humeca business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Medical Device Sales: Humeca generates revenue through the sale of medical devices and instruments for skin grafting and burn surgery, including dermatomes, meshers, knives, blades, and the MEEK micrografting system. Products are sold directly through subsidiaries and through distribution partners in over 80 countries.
- Consumables and Accessories: Recurring revenue from disposable blades, V-carriers, and prefolded gauzes used with the MEEK technique and dermatomes. Both D80 and D42 dermatomes use disposable blades to ensure sharp cutting.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels4 records
Humeca product offering
Product offeringCore offering
Humeca designs, manufactures, and distributes medical devices for burn surgery and skin grafting procedures. Its product portfolio includes the MEEK micrografting system, cordless dermatomes, manual meshers with V-carriers, and surgical knives/blades used by burn surgeons and plastic surgeons worldwide.
Product overview
Humeca is a Dutch medical device company specializing in skin transplantation instruments for burn surgery. The product portfolio centers on the MEEK Micrografting System—a technique that cuts skin grafts into precise 3mm micrografts and expands them onto wound beds at controlled ratios. Supporting this core are two cordless dermatomes (D80 for general use, D42 for the MEEK technique), skin graft meshers with V-carriers offering multiple expansion ratios, and a range of manual knives (Humby, Humby Long, Watson, Cobbett, Silver) for free-handed graft harvesting and debridement. All products are manufactured in the Netherlands and designed to work together as an integrated toolkit covering the entire skin grafting workflow from harvest to application.
Differentiator
Problem solved
Functional benefit
Products and services
- MEEK Micrografting System
Quantifiable outcome
- Epithelialization time for 1:6 expansion using MEEK is 3-4 weeks
- +3 more outcomes
Companies that use Humeca
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles1 record
Humeca technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Humeca partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- IntermedcoreIntermed is Humeca's new exclusive distributor for Australia and New Zealand, announced at ANZBA 2025. This partnership represents Humeca's first participation with Intermed at the ANZBA Conference, marking a transition from the previous distributor Ozmedix.
- MarsapcoreMarsap is Humeca's trusted local partner in India, collaborating at the Asia Pacific Burn Conference (APBC) 2025 in Goa. Marsap represents Humeca in the Indian market for burn care products.
- Ridge BiomedcoreRidge Biomed is Humeca's partner representing the company in Malaysia, participating at the 5th International Burn & Wound Conference in Kuching, Malaysia alongside APAC Sales Manager Ardy Karnadi.
- CENQUERcoreCENQUER hosted the first Meek Certification in Latin America in 2025, partnering with Humeca to advance burn care training. The certification program included 14 hours of theoretical instruction and a full week of hands-on training with 12 hours of practical work including 4 live surgeries.
- Stichting Interplast HollandminorStichting Interplast Holland is a humanitarian organization introducing the MEEK technique in Uganda. Humeca products are used in this mission alongside doctors from Dutch burn units (Maasstad/Rotterdam and Red Cross Hospital Beverwijk). Dr Annebeth de Vries leads teaching efforts.
- Burn Center Red Cross Hospital BeverwijkcoreHumeca developed the modified MEEK technique in cooperation with surgeons at the Burn Center Red Cross Hospital Beverwijk, The Netherlands. This partnership in the early 1990s led to the release of the modernized MEEK technique in 1993.
Scale indicators1 record
Recent moves7 records
Expansion highlights6 records
Humeca competitors and assessment
Company assessmentBroad incumbents
- Conmed: Medical device company offering surgical instruments and electrosurgery products, with adjacent presence in dermatomes and skin graft instrumentation for burn and plastic surgery.
- Zimmer Biomet: Large diversified medical device company with a surgical instruments portfolio including dermatomes. Broader scale and broader product portfolio than Humeca, but overlaps in skin graft harvesting instrumentation.
- Aesculap (B. Braun): B. Braun's surgical instruments division offering dermatomes and graft harvesting knives. Comparable to Humeca's manual knife line (Humby, Watson, Cobbett) and broader surgical instrument catalog.
- Integra LifeSciences: Wound care and surgical device company with regenerative tissue products and skin graft instrumentation. Adjacent competitor in burn wound management with broader portfolio.
- Smith & Nephew: Global medical device company with wound management and skin grafting products. Overlaps with Humeca in burn wound care and surgical instrumentation but operates at much larger scale.
- Organogenesis: Regenerative medicine company producing skin substitutes and wound care biologics (e.g., Apligraf). Operates in adjacent wound healing space with potential to compete with autografting techniques like MEEK.
- Stryker: Large diversified medical device company with surgical instruments portfolio relevant to burn surgery operating rooms. Comparable at the level of surgical device procurement relationships with hospitals.
Direct peers
- Exsurco Medical: Specialty manufacturer of dermatomes and skin graft products. Direct competitor to Humeca's D80/D42 dermatome product line in burn and reconstructive surgery markets.
Emerging players
- MiMedx: Regenerative medicine company specializing in placental tissue allografts for wound healing and surgical recovery. Competes indirectly with autografting for severe wound closure indications.
- Vericel Corporation: Cellular therapy company with autologous skin cell products (e.g., Epicel) for severe burns. Represents the regenerative medicine alternative to autografting techniques like Humeca's MEEK.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Humeca social profiles
Digital presenceHumeca compliance and trust
Trust signalCompliance1 record
Humeca financial estimates
Financial estimateRevenue estimate
Valuation estimate
Humeca leadership team
Management profileNumber of profiles
Profiles1 record
Humeca subsidiaries and ownership
Company hierarchySubsidiaries1 record
Humeca funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Humeca M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Humeca
What does Humeca do?
Humeca designs, manufactures, and distributes medical devices for burn surgery and skin grafting procedures. Its product portfolio includes the MEEK micrografting system, cordless dermatomes, manual meshers with V-carriers, and surgical knives/blades used by burn surgeons and plastic surgeons worldwide.
Is Humeca a public or private company?
Humeca is a private company. It is classified as venture growth investor backed and is currently operating.
When was Humeca founded?
Humeca was founded in 1981. It employs 1 to 10 people.
Where is Humeca based?
Humeca is headquartered in Borne, Netherlands, in the Europe region.
How does Humeca make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are consumables and Accessories.
Who are Humeca's main competitors?
Broad incumbents on record are Conmed, Zimmer Biomet, Aesculap (B. Braun), Integra LifeSciences, Smith & Nephew, Organogenesis and Stryker. Exsurco Medical is listed as a direct peer. Emerging players are MiMedx and Vericel Corporation.
Does Humeca have an API?
No public API is recorded for Humeca.
What industry is Humeca in?
Humeca's product category is Medical Devices for Burn Surgery / Skin Grafting Equipment. Its primary akta.pro industry code is HLAHALAE, Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts), with a secondary code of HLAAAGAG, Wound Healing & Skin Regeneration (advanced dressings, skin substitutes). Its NAICS code is 339112 and its SIC code is 3841.